Pliva is the largest pharmaceutical company, by turnover, within Central and Eastern Europe. The company’s therapeutic areas include alimentary and metabolism, anticancer, anti-infective, inflammation/musculoskeletal and respiratory. Principal products marketed are Analgin®, Betrion®, Cilazil®, Gluformin®, Ketocef®, Oikamid® and Sumamed®. PLIVA intends to strengthen its business activities especially in Western Europe and within US markets.